AXGN
Axogen, Inc.
Medical Devices · Healthcare · United States
49.63
close · 2026-10-29
value
14
cheaper than peers14
quality
80
stronger fundamentals80
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 2 years ago | -1.0% | 59 |
| earnings yield, 1 year ago | -0.5% | 50 |
| earnings yield, 3 years ago | -1.4% | 41 |
| earnings yield, latest year | -0.7% | 32 |
| cash flow yield, 3 years ago | -1.4% | 23 |
| forward P/E | 69.91× | 15 |
| cash flow yield, latest year | -0.2% | 14 |
| cash flow yield, 1 year ago | 0.0% | 14 |
| cash flow yield, 2 years ago | -0.8% | 14 |
| price to sales | 11.50× | 11 |
| price to book | 18.18× | 7 |
11 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 7.8% | 82 |
| revenue growth | 23.1% | 81 |
| operating margin | -3.1% | 54 |
| return on equity | -18.2% | 48 |
4 of 4 measures available
Facts
| market cap | $3B |
| free cash flow | $18.2M |
| employees | 622 |
| first trade | 1986-12-17 |
| next earnings | 2026-10-28 |
| fundamentals updated | 2026-10-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.34 | -0.23 | -0.51 | -0.69 |
| free cash flow | -$4.8M | $11,000 | -$20.6M | -$37.3M |
| net income | -$15.7M | -$10.0M | -$21.7M | -$28.9M |
| revenue | $225.2M | $187.3M | $159.0M | $138.6M |
| unusual items | -$319,000 | $1.7M | $3.0M | $1.6M |